{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T14:11:39Z","timestamp":1772115099948,"version":"3.50.1"},"reference-count":130,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.eimc.2012.12.011","type":"journal-article","created":{"date-parts":[[2013,2,12]],"date-time":"2013-02-12T08:05:14Z","timestamp":1360656314000},"page":"240-253","source":"Crossref","is-referenced-by-count":57,"title":["Tos ferina en Espa\u00f1a. Situaci\u00f3n epidemiol\u00f3gica y estrategias de prevenci\u00f3n y control. Recomendaciones del Grupo de Trabajo de Tos ferina"],"prefix":"10.1016","volume":"31","author":[{"given":"Magda","family":"Campins","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Moreno-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angel","family":"Gil-de Miguel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Gonz\u00e1lez-Romo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando A.","family":"Moraga-Llop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Ar\u00edstegui-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Gonc\u00e9-Mellgren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 M.","family":"Bayas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Llu\u00eds","family":"Salleras-Sanmart\u00ed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eimc.2012.12.011_bib0005","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S1473-3099(11)70007-X","article-title":"Rationale for pertussis booster vaccination throughout life in Europe","volume":"11","author":"Zepp","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.eimc.2012.12.011_bib0010","unstructured":"EUVAC-NET pertussis surveillance final report 1998-2002. 2003. [consultado 26 ene 2013]. Disponible en: http:\/\/www.euvac.net\/graphics\/euvac\/pdf\/pertussis1.pdf"},{"key":"10.1016\/j.eimc.2012.12.011_bib0015","unstructured":"European Centre for Disease Prevention and Control. EUVAC.NET. Pertussis surveillance report 2010. [consultado 26 ene 2013]. Disponible en: http:\/\/www.euvac.net\/graphics\/euvac\/pdf\/pertussis_2010.pdf"},{"key":"10.1016\/j.eimc.2012.12.011_bib0020","first-page":"121","article-title":"Whooping cough surveillance in the north west of England","volume":"1","author":"Devine","year":"1998","journal-title":"Commun Dis Public Health"},{"key":"10.1016\/j.eimc.2012.12.011_bib0025","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1097\/00006454-200208000-00013","article-title":"Pediatric sentinel surveillance of vaccine-preventable diseases in Italy","volume":"21","author":"Ciofi degli Atti","year":"2002","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.eimc.2012.12.011_bib0030","doi-asserted-by":"crossref","first-page":"19548","DOI":"10.2807\/ese.15.16.19548-en","article-title":"Changes to the varicella and pertussis immunisation schedule in Germany 2009: background, rationale and implementation","volume":"15","author":"Wiese-Posselt","year":"2010","journal-title":"Eurosurveillance"},{"key":"10.1016\/j.eimc.2012.12.011_bib0035","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/INF.0b013e318161a2b9","article-title":"Impact of acellular pertussis preschool booster vaccination on disease burden of pertussis in The Netherlands","volume":"27","author":"De Greeff","year":"2008","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.eimc.2012.12.011_bib0040","unstructured":"Health Protection Agency. Guidelines for the public health management of pertussis. Updated October, 2012. [consultado 26 ene 2013]. Disponible en: www.hpa.org.uk"},{"key":"10.1016\/j.eimc.2012.12.011_bib0045","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1517\/14712598.6.7.685","article-title":"Pertussis immunisation in adolescents and adults \u2014 Bordetella pertussis epidemiology should guide vaccination recommendations","volume":"6","author":"Heininger","year":"2006","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.eimc.2012.12.011_bib0050","unstructured":"Ministerio de Sanidad, Pol\u00edtica Social e Igualdad. Coberturas de vacunaci\u00f3n. Datos estad\u00edsticos. [consultado 26 ene 2013]. Disponible en: http:\/\/www.msc.es\/profesionales\/saludPublica\/prevPromocion\/vacunaciones\/coberturas.htm"},{"key":"10.1016\/j.eimc.2012.12.011_bib0055","unstructured":"Situaci\u00f3n de la tos ferina en Espa\u00f1a. Red Nacional de Vigilancia Epidemiol\u00f3gica de Espa\u00f1a. A\u00f1o 2009. Centro Nacional de Epidemiolog\u00eda. Instituto de Salud Carlos III. [consultado 18 dic 2011]. Disponible en: http:\/\/www.isciii.es\/htdocs\/centros\/epidemiologia\/pdf\/Informetosferinajunio2009.pdf"},{"key":"10.1016\/j.eimc.2012.12.011_bib0060","first-page":"247","article-title":"Estado de las enfermedades de declaraci\u00f3n obligatoria","volume":"19","year":"2011","journal-title":"BES"},{"key":"10.1016\/j.eimc.2012.12.011_bib0065","unstructured":"Garc\u00eda M, Campins M, Roca J, Moraga F, Baquero F, Gen\u00e9 A, et al. Bordetella pertussis infection in infants and their household contacts. 4th Congress of the World Society for Pediatric Infectious Diseases (WSPID). Varsovia (Polonia), 1-4 de septiembre de 2005 (abstract book, p. 49)."},{"key":"10.1016\/j.eimc.2012.12.011_bib0070","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/01.inf.0000256750.07118.ee","article-title":"Prospective multinational study of pertussis infection in hospitalized infants and their household contacts","volume":"26","author":"Kowalzik","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.eimc.2012.12.011_bib0075","series-title":"XVII Jornadas Internacionales sobre Actualizaci\u00f3n en Vacunas, 2009","first-page":"53","article-title":"Importancia de la tos ferina en el lactante. Justificaci\u00f3n de una nueva estrategia para su prevenci\u00f3n","author":"Iglesias","year":"2009"},{"key":"10.1016\/j.eimc.2012.12.011_bib0080","article-title":"Estudio de contactos de casos pedi\u00e1tricos de tos ferina en un hospital de tercer nivel de Barcelona","author":"Uriona","year":"2012","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.eimc.2012.12.011_bib0085","series-title":"Vacunaciones del adolescente","first-page":"931","year":"2003"},{"key":"10.1016\/j.eimc.2012.12.011_bib0090","series-title":"Vacunas","first-page":"1411","article-title":"Pol\u00edticas vacunales oficiales en Espa\u00f1a","author":"Salleras","year":"2007"},{"key":"10.1016\/j.eimc.2012.12.011_bib0095","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1097\/01.inf.0000164701.50766.62","article-title":"Epidemiology and surveillance of pertussis among infants in Catalonia, Spain, during 1997-2001","volume":"24","author":"Moraga","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.eimc.2012.12.011_bib0100","first-page":"1","article-title":"Resultats del programa pilot de vigil\u00e0ncia de la tos ferina a Cataluya","volume":"26","year":"2005","journal-title":"Butllet\u00ed Epidemiol\u00f2gic de Catalunya"},{"key":"10.1016\/j.eimc.2012.12.011_bib0105","unstructured":"Romero M, Dom\u00ednguez A, Carde\u00f1osa N, Carmona G, Codina G, Fuentes M, and the Catalonia Pertussis Working Group. Detection of cases of pertussis by a surveillance programme: revaccination concerns. Fifth World Congress on Vaccines, Immunization and Immunotherapy (WCVII 2006 CANADA). Montreal, 6-9 november 2006; poster P-1.1."},{"key":"10.1016\/j.eimc.2012.12.011_bib0110","series-title":"Clasificaci\u00f3n internacional de enfermedades, 9.\u00aa revisi\u00f3n modificaci\u00f3n cl\u00ednica","year":"1994"},{"key":"10.1016\/j.eimc.2012.12.011_bib0115","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.vaccine.2006.07.023","article-title":"Comparison of pertussis surveillance systems in Europe","volume":"25","author":"Tozzi","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.eimc.2012.12.011_bib0120","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S1576-9887(09)72267-8","article-title":"Epidemiolog\u00eda de las hospitalizaciones atribuibles a tos ferina en ni\u00f1os menores de 12 meses en Espa\u00f1a (1999-2005)","volume":"10","author":"Gil Prieto","year":"2009","journal-title":"Vacunas"},{"key":"10.1016\/j.eimc.2012.12.011_bib0125","doi-asserted-by":"crossref","first-page":"4791","DOI":"10.1016\/S0264-410X(01)00213-4","article-title":"Hospital admissions for pertussis in Spain, 1995-1998","volume":"19","author":"Gil","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.eimc.2012.12.011_bib0130","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S1576-9887(08)72493-2","article-title":"Epidemiolog\u00eda de las hospitalizaciones atribuibles a infecci\u00f3n por Bordetella pertussis en poblaci\u00f3n general en Espa\u00f1a, 1999-2005","volume":"9","author":"Santos","year":"2008","journal-title":"Vacunas"},{"key":"10.1016\/j.eimc.2012.12.011_bib0135","series-title":"Enfermedades infecciosas. Principios y pr\u00e1ctica","article-title":"G\u00e9nero Bordetella","author":"Hewlett","year":"2011"},{"key":"10.1016\/j.eimc.2012.12.011_bib0140","doi-asserted-by":"crossref","first-page":"e1072","DOI":"10.1016\/j.ijid.2010.07.005","article-title":"Sensivitiy and specificity of the World Health Organization pertussis clinical case definition","volume":"14","author":"Ghanaie","year":"2010","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.eimc.2012.12.011_bib0145","unstructured":"World Health Organization. Recommended standards for surveillance of selected vaccine-preventable diseases. Immunization surveillance, assessment and monitoring. WHO; 2003. [consultado 26 ene 2013]. Disponible en: http:\/\/www.who.int\/immunization_monitoring\/diseases\/pertussis_surveillance\/en\/index.html"},{"key":"10.1016\/j.eimc.2012.12.011_bib0150","unstructured":"Faulkner A, Skoff T, Martin S, Cassiday P, Tondella ML, Liang J, et al. Pertusis. En: Roush SW, McIntyre L, Baldy LM, editores. Centers for Disease Control and Prevention. Manual for the surveillance of vaccine-preventable diseases. 5th ed. 2012. [consultado 26 ene 2013]. Disponible en: http:\/\/www.cdc.gov\/vaccines\/pubs\/surv-manual\/index.html"},{"key":"10.1016\/j.eimc.2012.12.011_bib0155","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1093\/cid\/cis302","article-title":"Clinical definitions of pertussis: summary of a global pertussis initiative roundtable meeting, February 2011","volume":"54","author":"Cherry","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2012.12.011_bib0160","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1136\/archdischild-2011-300901","article-title":"Question 3. Is measurement of the lymphocyte count useful in the investigation of suspected pertussis in infants?","volume":"96","author":"Levene","year":"2011","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.eimc.2012.12.011_bib0165","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1503\/cmaj.1040766","article-title":"Diagnosis and management of pertussis","volume":"172","author":"Tozzi","year":"2005","journal-title":"CMAJ"},{"key":"10.1016\/j.eimc.2012.12.011_bib0170","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3109\/1040841X.2011.622715","article-title":"The diagnosis of pertussis: which method to choose","volume":"38","author":"Zouari","year":"2012","journal-title":"Crit Rev Microbiol"},{"key":"10.1016\/j.eimc.2012.12.011_bib0175","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1590\/S0036-36342011000100009","article-title":"Consenso para el diagn\u00f3stico cl\u00ednico y microbiol\u00f3gico y la prevenci\u00f3n de la infecci\u00f3n por Bordetella pertussis","volume":"53","year":"2011","journal-title":"Salud Publica Mex"},{"key":"10.1016\/j.eimc.2012.12.011_bib0180","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.vaccine.2010.12.010","article-title":"The Global Pertussis Initiative: report from a round table meeting to discuss the epidemiology and detection of pertussis. Paris, France, 11-12 January 2010","volume":"29","author":"Guiso","year":"2011","journal-title":"Vaccine"},{"issue":"5 Suppl","key":"10.1016\/j.eimc.2012.12.011_bib0185","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1097\/01.inf.0000160707.44131.ae","article-title":"The Global Pertussis Initiave: process overview","volume":"24","author":"Plotkin","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.eimc.2012.12.011_bib0190","series-title":"Best practices for health care professionals on the use of polymerase chain reaction (PCR) for diagnosing pertussis. 2011","year":"2011"},{"key":"10.1016\/j.eimc.2012.12.011_bib0195","doi-asserted-by":"crossref","first-page":"3943","DOI":"10.1128\/JCM.00335-11","article-title":"Evaluation of four commercial real-time PCR assays for detection of Bordetella spp in nasofaryngeal aspirates","volume":"49","author":"Lanotte","year":"2011","journal-title":"Clin Microbiol"},{"key":"10.1016\/j.eimc.2012.12.011_bib0200","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s10096-011-1327-6","article-title":"The laboratory diagnosis of Bordetella pertussis infection: a comparison of semi-nested PCR and real-time PCR with culture","volume":"31","author":"Abu Raya","year":"2012","journal-title":"Eur J Clin Micriobiol Infect Dis"},{"key":"10.1016\/j.eimc.2012.12.011_bib0205","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1128\/CMR.19.1.165-256.2006","article-title":"Real-time PCR in clinical microbiology: applications for routine laboratory testing","volume":"19","author":"Espy","year":"2006","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.eimc.2012.12.011_bib0210","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1756-0500-4-11","article-title":"A real-time PCR assay with improved specificity for detection and discrimination of all clinically relevant Bordetella species by the presence and distribution of three insertion sequence elements","volume":"4","author":"Roorda","year":"2011","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.eimc.2012.12.011_bib0215","doi-asserted-by":"crossref","first-page":"4059","DOI":"10.1128\/JCM.00601-11","article-title":"Novel multitarget real-time PCR assay for rapid detection of Bordetella species in clinical specimens","volume":"49","author":"Tatti","year":"2011","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.eimc.2012.12.011_bib0220","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s10096-010-1104-y","article-title":"What to do and what not to do in serological diagnosis of pertussis: recommendations from EU reference laboratories","volume":"30","author":"Guiso","year":"2011","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.eimc.2012.12.011_bib0225","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1136\/adc.2004.068783","article-title":"Are new macrolides effective in eradicating carriage of pertussis","volume":"90","author":"Srinivasan","year":"2005","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.eimc.2012.12.011_bib0230","first-page":"1","article-title":"Recommended antimicrobial agents for treatment and postexposure prophylaxis of pertussis: 2005 CDC guidelines","volume":"54","year":"2005","journal-title":"MMWR"},{"key":"10.1016\/j.eimc.2012.12.011_bib0235","series-title":"Red Book: 2012 Report of the Committee on Infectious Diseases","first-page":"553","article-title":"Pertussis (whooping cough)","year":"2012"},{"key":"10.1016\/j.eimc.2012.12.011_bib0240","first-page":"23","volume":"2953","year":"2003","journal-title":"Can Commun Dis Rep"},{"key":"10.1016\/j.eimc.2012.12.011_bib0245","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1093\/pubmed\/24.3.200","article-title":"UK guidelines for use of erythromycin chemoprophylaxis in persons exposed to pertussis","volume":"24","author":"Dodhia","year":"2002","journal-title":"J Public Health Med"},{"key":"10.1016\/j.eimc.2012.12.011_bib0250","doi-asserted-by":"crossref","first-page":"e96","DOI":"10.1542\/peds.114.1.e96","article-title":"Azithromycin is as effective as and better tolerated than erythromycin estolate for the treatment of pertussis","volume":"114","author":"Langley","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.eimc.2012.12.011_bib0255","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1097\/00006454-200112000-00011","article-title":"Efficacy and safety of clarithromycin versus erythromycin for the treatment of pertussis: a prospective, randomized, single blind trial","volume":"20","author":"Lebel","year":"2001","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.eimc.2012.12.011_bib0260","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/MAJ.0b013e318184e72f","article-title":"Compliance with azithromycin versus erythromycin in the setting of a pertussis outbreak","volume":"337","author":"Devasia","year":"2009","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.eimc.2012.12.011_bib0265","doi-asserted-by":"crossref","unstructured":"Altunaiji S, Kukuruzovic R, Curtis N, Massie J. Antibiotics for whooping cough (pertussis). Cochrane Database Syst Rev. 2007; 3:CD004404. [consultado 26 ene 2013]. Disponible en: http:\/\/summaries.cochrane.org\/CD004404","DOI":"10.1002\/14651858.CD004404.pub3"},{"key":"10.1016\/j.eimc.2012.12.011_bib0270","doi-asserted-by":"crossref","first-page":"388","DOI":"10.5694\/j.1326-5377.2009.tb02455.x","article-title":"Pertussis prevention and treatment: a call for wider access to azithromycin","volume":"190","author":"Bowen","year":"2009","journal-title":"Med J Aust"},{"key":"10.1016\/j.eimc.2012.12.011_bib0275","doi-asserted-by":"crossref","first-page":"929","DOI":"10.2165\/00002018-200225130-00004","article-title":"The association of erythromycin and infantile hypertrophic pyloric stenosis: causal or coincidental","volume":"25","author":"Hauben","year":"2002","journal-title":"Drug Saf"},{"key":"10.1016\/j.eimc.2012.12.011_bib0280","series-title":"Vacunas","first-page":"481","article-title":"Vacuna anti-tos ferina","author":"Edwards","year":"2007"},{"key":"10.1016\/j.eimc.2012.12.011_bib0285","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1542\/peds.96.3.548","article-title":"Comparison of 13 acellular pertussis vaccines: overview and serologic response","volume":"96","author":"Edwards","year":"1995","journal-title":"Pediatrics"},{"key":"10.1016\/j.eimc.2012.12.011_bib0290","first-page":"58","article-title":"A comparative efficacy trial in Germany in which infants received either the Lederle\/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP (DTP) vaccine or DT vaccine","volume":"89","author":"Stehr","year":"1997","journal-title":"Dev Biol Stand"},{"key":"10.1016\/j.eimc.2012.12.011_bib0295","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1128\/CVI.00469-09","article-title":"Antibody response patterns to Bordetella pertussis antigens in vaccinated (primed) and unvaccinated (unprimed) young children with pertussis","volume":"17","author":"Cherry","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.eimc.2012.12.011_bib0300","first-page":"CD001478","article-title":"Acellular vaccines for preventing whooping cough in children","volume":"3","author":"Zhang","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.eimc.2012.12.011_bib0305","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1586\/14760584.4.2.173","article-title":"Acellular pertussis vaccines in Japan: past, present and future","volume":"4","author":"Watanabe","year":"2005","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.eimc.2012.12.011_bib0310","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1586\/erv.09.88","article-title":"Efficacy and effectiveness of acellular pertussis vaccines: a 20-year Swedish experience","volume":"8","author":"Hallander","year":"2009","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.eimc.2012.12.011_bib0315","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1016\/j.vaccine.2011.10.089","article-title":"Pertussis vaccination in infancy lowers the incidence of pertussis disease and the rate of hospitalization after one and two doses: analysis of 10 years of pertussis surveillance","volume":"30","author":"Nilsson","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.eimc.2012.12.011_bib0320","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1542\/peds.96.3.557","article-title":"Comparison of 13 acellular pertussis vaccines: adverse reactions","volume":"96","author":"Decker","year":"1995","journal-title":"Pediatrics"},{"key":"10.1016\/j.eimc.2012.12.011_bib0325","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1016\/S0264-410X(02)00770-3","article-title":"Systematic review of the effects of pertussis vaccines in children","volume":"21","author":"Jefferson","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.eimc.2012.12.011_bib0330","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1345\/aph.1M468","article-title":"New combination vaccines: DTaP-IPV (Kinrix) and DTaP-IPV\/Hib (Pentacel)","volume":"44","author":"Johns","year":"2010","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.eimc.2012.12.011_bib0335","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1586\/erv.11.72","article-title":"A DTaP-IPV\/RPR-T vaccine (Pentaxim): a review of 16 years\u2019 clinical experience","volume":"10","author":"Plotkin","year":"2011","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.eimc.2012.12.011_bib0340","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1586\/erv.09.32","article-title":"Review of 8 years of experience with Infanrix hexa (DTPa-HBV-IPV\/Hib hexavalent vaccine)","volume":"8","author":"Zepp","year":"2009","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.eimc.2012.12.011_bib0345","unstructured":"Ficha t\u00e9cnica de Boostrix\u00ae. [consultado 26 ene 2013]. Disponible en: http:\/\/www.aemps.gob.es\/cima\/especialidad.do?metodo=verFichaWordPdf&codigo=63993&formato=pdf&formulario=FICHAS&file=ficha.pdf"},{"key":"10.1016\/j.eimc.2012.12.011_bib0350","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1016\/S0264-410X(99)00568-X","article-title":"A randomised controlled trial with a diphteria-tetanus acellular pertussis (dTpa) vaccine in adults","volume":"18","author":"Van der Wielen","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.eimc.2012.12.011_bib0355","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1016\/S0264-410X(01)00029-9","article-title":"Immunogenicity and reactogenicity of a single dose of a diphteria-tetanus-acellular pertussis component vaccine (DtaP) compared to a diphteria-tetanus toxoid (Td and a diphteria toxoid vaccine (d) in adults","volume":"19","author":"Bartels","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.eimc.2012.12.011_bib0360","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.vaccine.2004.05.030","article-title":"High levels of antibody in adults three years after vaccination with a reduced antigen content diphteria-tetanus-acellular pertussis vaccine","volume":"23","author":"McIntyre","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.eimc.2012.12.011_bib0365","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1086\/422035","article-title":"Immune responses and antibody decay after immunization of adolescents and adults with an acellular pertussis vaccine: the APERT Study","volume":"190","author":"Le","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.eimc.2012.12.011_bib0370","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.jpeds.2006.06.016","article-title":"Safety of reduced-antigen-content tetanus-diphtheria-acellular pertussis vaccine in adolescents as a sixth consecutive dose of acellular pertussis-containing vaccine","volume":"149","author":"Zepp","year":"2006","journal-title":"J Pediatr"},{"key":"10.1016\/j.eimc.2012.12.011_bib0375","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1056\/NEJMoa1200850","article-title":"Waning protection after fifth dose of acellular pertussis vaccine in children","volume":"367","author":"Klein","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eimc.2012.12.011_bib0380","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1086\/504803","article-title":"Bordetella pertussis infections in vaccinated and unvaccinated adolescents and adults, as assessed in a national prospective randomized acellular pertussis vaccine trial (APERT)","volume":"43","author":"Ward","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2012.12.011_bib0385","doi-asserted-by":"crossref","first-page":"203","DOI":"10.4161\/hv.4.3.5290","article-title":"Immunogenicity and reactogenicity of acellular pertusis booster vaccines in children","volume":"4","author":"Meyer","year":"2008","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.eimc.2012.12.011_bib0390","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1056\/NEJMoa050824","article-title":"Efficacy of an acellular pertussis vaccine among adolescents and adults","volume":"353","author":"Ward","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eimc.2012.12.011_bib0395","unstructured":"Ficha t\u00e9cnica de Triaxis\u00ae. [consultado 26 ene 2013]. Disponible em: http:\/\/www.aemps.gob.es\/cima\/especialidad.do?metodo=verFichaWordPdf&codigo=71870&formato=pdf&formulario=FICHAS&file=ficha.pdf"},{"key":"10.1016\/j.eimc.2012.12.011_bib0400","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/INF.0b013e31818a8958","article-title":"Pertussis vaccine: a critique","volume":"28","author":"Robbins","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.eimc.2012.12.011_bib0405","unstructured":"European Centre for Disease Prevention and Control. Pertussis vaccination overview in European countries. [consultado 30 oct 2012]. Disponible en: http:\/\/ecdc.europa.eu\/en\/activities\/surveillance\/euvac\/schedules\/Pages\/pertussis_schedule.aspx"},{"key":"10.1016\/j.eimc.2012.12.011_bib0410","unstructured":"WHO. Countries in the world with Tdpa vaccine in adolescents. [consultado 30 oct 2012]. Disponible en: http:\/\/apps.who.int\/immunization_monitoring\/en\/globalsummary\/ScheduleResult.cfm"},{"key":"10.1016\/j.eimc.2012.12.011_bib0415","first-page":"279","article-title":"Impfempfehlungen der St\u00e4ndigen Impfkommission am Robert Koch-Institut\/Stand Juli 2009","volume":"30","year":"2009","journal-title":"Epidem Bull"},{"key":"10.1016\/j.eimc.2012.12.011_bib0420","first-page":"146","article-title":"Vaccination schedules and recommendations from the Haut Conseil de la Sant\u00e9 publique in France","volume":"16-17","year":"2009","journal-title":"Bulletin \u00c9pid\u00e9miologique Hebdomadaire"},{"key":"10.1016\/j.eimc.2012.12.011_bib0425","unstructured":"Conseil Sup\u00e9rieur de la Sant\u00e9. Vaccination anticoquelucheuse (fichier 8547). Vaccination de l\u2019adulte. 2009. [consultado 20 oct 2012]. Disponible en: http:\/\/www.belgium.be\/en\/health\/"},{"key":"10.1016\/j.eimc.2012.12.011_bib0430","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1056\/NEJMp1209051","article-title":"Epidemic Pertussis in 2012 \u2014 The Resurgence of a Vaccine-Preventable Disease","volume":"367","author":"Cherry","year":"2012","journal-title":"NEJM"},{"key":"10.1016\/j.eimc.2012.12.011_bib0435","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0264-410X(01)00393-0","article-title":"Recommendations are needed for adolescent and adult pertussis immunization: rationale and strategies for consideration","volume":"20","author":"Campins-Mart\u00ed","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.eimc.2012.12.011_bib0440","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1086\/426020","article-title":"New pertussis vaccination strategies beyond infancy: recommendations by the Global Pertussis Initiative","volume":"39","author":"Forsyth","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"Supl 1","key":"10.1016\/j.eimc.2012.12.011_bib0445","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0213-005X(08)76221-9","article-title":"Vacunaci\u00f3n frente a la tos ferina en el adolescente y el adulto","volume":"26","author":"Campins","year":"2008","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.eimc.2012.12.011_bib0450","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1155\/2005\/642315","article-title":"A comparison of pertussis rates in the Norwest Terrritories: pre- and postacellular pertussis vaccine introduction in children and adolescents","volume":"16","author":"Kandola","year":"2005","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"10.1016\/j.eimc.2012.12.011_bib0455","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/INF.0b013e318199d2fc","volume":"28","author":"Greenberg","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.eimc.2012.12.011_bib0460","first-page":"197","article-title":"SAGE. Meeting of the Strategic Advisory Group of Experts on immunization, April 2010 \u2014 conclusions and recommendations","volume":"85","year":"2010","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.eimc.2012.12.011_bib0465","doi-asserted-by":"crossref","first-page":"666","DOI":"10.2471\/BLT.11.086538","article-title":"The impact of adolescent pertussis immunization, 2004-2009: lessons from Australia","volume":"89","author":"Quinn","year":"2011","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.eimc.2012.12.011_bib0470","doi-asserted-by":"crossref","first-page":"59.e1","DOI":"10.1016\/j.anpedi.2012.10.002","article-title":"Calendario de vacunaciones de la Asociaci\u00f3n Espa\u00f1ola de Pediatr\u00eda: recomendaciones 2013","volume":"78","author":"Moreno-P\u00e9rez","year":"2013","journal-title":"An Pediatr (Barc)"},{"key":"10.1016\/j.eimc.2012.12.011_bib0475","unstructured":"Vacuna de difteria y t\u00e9tanos. Vacunaci\u00f3n en adultos. Recomendaciones. Ministerio de Sanidad y Pol\u00edtica Social. Febrero 2009. [consultado 26 ene 2013]. Disponible en: http:\/\/www.msps.es\/ciudadanos\/proteccionSalud\/vacunaciones\/docs\/TetanosDifteria_2009.pdf"},{"key":"10.1016\/j.eimc.2012.12.011_bib0480","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1086\/655825","article-title":"Decennial administration of a reduced antigen content diphtheria and tetanus toxoids and acellular pertussis vaccine in young adults","volume":"51","author":"Mertsola","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2012.12.011_bib0485","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.vaccine.2010.10.025","article-title":"A decennial booster dose of reduced antigen content diphtheria, tetanus, acellular pertussis vaccine (Boostrix\u2122) is immunogenic and well tolerated in adults","volume":"29","author":"Booy","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.eimc.2012.12.011_bib0490","first-page":"E11","article-title":"Nosocomial infections and community clusters of pertussis in France, 2000-2005","volume":"12","author":"Bonmarin","year":"2007","journal-title":"Euro Surveill"},{"key":"10.1016\/j.eimc.2012.12.011_bib0495","doi-asserted-by":"crossref","first-page":"568","DOI":"10.5694\/j.1326-5377.2002.tb04956.x","article-title":"Pertussis: adults as a source in healthcare settings","volume":"177","author":"Spearing","year":"2002","journal-title":"Med J Australia"},{"key":"10.1016\/j.eimc.2012.12.011_bib0500","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1086\/502541","article-title":"Health and economic consequences of an outbreak of pertussis among healthcare workers in a hospital in France","volume":"26","author":"Ward","year":"2005","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.eimc.2012.12.011_bib0505","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1086\/500321","article-title":"Nosocomial pertussis: costs of an outbreak and benefits of vaccinating health care workers","volume":"42","author":"Calugar","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2012.12.011_bib0510","first-page":"385","article-title":"Pertussis vaccines: WHO position paper","volume":"85","year":"2010","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.eimc.2012.12.011_bib0515","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/01.inf.0000258699.64164.6d","article-title":"Transmission of Bordetella pertussis to young infants","volume":"26","author":"Wendelboe","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.eimc.2012.12.011_bib0520","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1097\/01.inf.0000145263.37198.2b","article-title":"Infant pertussis: who was the source","volume":"23","author":"Bisgard","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.eimc.2012.12.011_bib0525","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1086\/652281","article-title":"Pertussis disease burden in the household: how to protect young infants","volume":"50","author":"De Greeff","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2012.12.011_bib0530","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1136\/adc.88.9.802","article-title":"Severe and unrecognised: pertussis in UK infants","volume":"88","author":"Crowcroft","year":"2003","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.eimc.2012.12.011_bib0535","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1086\/514792","article-title":"Epidemiological features of pertussis in hospitalized patients in Canada, 1991-1997: report of the Immunization Monitoring Program-Active (IMPACT)","volume":"28","author":"Halperin","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2012.12.011_bib0540","doi-asserted-by":"crossref","first-page":"34","DOI":"10.2807\/esm.12.01.00678-en","article-title":"Pertussis surveillance in French hospitals: results from a 10 year period","volume":"12","author":"Bonmarin","year":"2007","journal-title":"Euro Surveill"},{"key":"10.1016\/j.eimc.2012.12.011_bib0545","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1093\/cid\/cir765","article-title":"Impact of maternal postpartum tetanus and diphtheria toxoids and acellular pertussis immunization on infant pertussis infection","volume":"54","author":"Castagnini","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2012.12.011_bib0550","first-page":"1424","volume":"60","year":"2011","journal-title":"MMWR"},{"key":"10.1016\/j.eimc.2012.12.011_bib0555","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1093\/cid\/ciq001","article-title":"Implementation of cocooning against pertussis in a high-risk population","volume":"52","author":"Healy","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2012.12.011_bib0560","series-title":"Vacunas","first-page":"9","article-title":"Tos ferina: \u00bfconocemos su incidencia real y c\u00f3mo controlarla?","author":"Moraga-Llop","year":"2005"},{"key":"10.1016\/j.eimc.2012.12.011_bib0565","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1016\/j.vaccine.2006.12.017","article-title":"Prevention of pertussis: recommendations derived from the second Global Pertussis Initiative roundtable meeting","volume":"25","author":"Forsyth","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.eimc.2012.12.011_bib0570","first-page":"1424","volume":"60","year":"2011","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.eimc.2012.12.011_bib0575","doi-asserted-by":"crossref","first-page":"e6284","DOI":"10.1371\/journal.pone.0006284","article-title":"Adult vaccination strategies for the control of pertussis in the United States: an economic evaluation including the dynamic population effects","volume":"4","author":"Coudeville","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.eimc.2012.12.011_bib0580","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/j.clinthera.2010.07.017","article-title":"Cost-effectiveness analysis of various pertussis vaccination strategies primarily aimed at protecting infants in The Netherlands","volume":"32","author":"Westra","year":"2010","journal-title":"Clin Ther"},{"key":"10.1016\/j.eimc.2012.12.011_bib0585","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1093\/cid\/cir836","article-title":"The number needed to vaccinate to prevent infant pertussis hospitalization and death through parent cocoon immunization","volume":"54","author":"Skowronski","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2012.12.011_bib0590","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1093\/cid\/cir846","article-title":"Infant pertussis: what to do next","volume":"54","author":"Healy","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2012.12.011_bib0595","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/INF.0b013e3181bc98d5","article-title":"Acellular pertussis vaccine at birth and one month induces antibody responses by two months","volume":"29","author":"Wood","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.eimc.2012.12.011_bib0600","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/QCO.0b013e328345d563","article-title":"Neonatal immunization: where do we stand","volume":"24","author":"Wood","year":"2011","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.eimc.2012.12.011_bib0605","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1542\/peds.111.5.1042","article-title":"Immunogenicity of a three-component acellular pertussis vaccine administered at birth","volume":"111","author":"Belloni","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/j.eimc.2012.12.011_bib0610","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.jpeds.2007.09.034","article-title":"Neonatal vaccination with an acellular pertussis vaccine accelerates the acquisition of pertussis antibodies in infants","volume":"152","author":"Knuf","year":"2008","journal-title":"J Pediatr"},{"key":"10.1016\/j.eimc.2012.12.011_bib0615","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jpeds.2008.03.011","article-title":"Poor immune responses to a birth dose of diphteria, tetanus and acellular pertussis vaccine","volume":"153","author":"Halasa","year":"2008","journal-title":"J Pediatr"},{"key":"10.1016\/j.eimc.2012.12.011_bib0620","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.jpeds.2009.12.019","article-title":"Booster vaccination after neonatal priming with acellular pertussis vaccine","volume":"156","author":"Knuf","year":"2010","journal-title":"J Pediatr"},{"key":"10.1016\/j.eimc.2012.12.011_bib0625","doi-asserted-by":"crossref","first-page":"9411","DOI":"10.1016\/j.vaccine.2011.11.009","article-title":"A maternal immunization program (MIP): developing a schedule and platform for routine immunization during pregnancy","volume":"29","author":"Gall","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.eimc.2012.12.011_bib0630","unstructured":"Centers for Disease Control and Prevention (CDC). Pertussis (whooping cough) vaccination. [consultado 26 ene 2013]. Disponible en: http:\/\/www.cdc.gov\/vaccines\/vpd-vac\/pertussis\/default.htm"},{"key":"10.1016\/j.eimc.2012.12.011_bib0635","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1097\/AOG.0b013e31824e1327","article-title":"Update on immunization and pregnancy: tetanus, diphtheria, and pertussis vaccination. Committee opinion No. 521","volume":"119","year":"2012","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.eimc.2012.12.011_bib0640","unstructured":"The Joint Committee on Vaccination and Immunisation (JCVI). Temporary programme of pertussis (whooping cough) vaccination of pregnant women, September 27th 2012. [consultado 26 ene 2013]. Disponible en: https:\/\/www.wp.dh.gov.uk\/publications\/files\/2012\/09\/CMO-Pertussis-27-09-2012-FINAL.pdf"},{"key":"10.1016\/j.eimc.2012.12.011_bib0645","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.ajog.2012.05.006","article-title":"Adverse event reports after tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccines in pregnant women","volume":"207","author":"Zheteyeva","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.eimc.2012.12.011_bib0650","unstructured":"Garret A. Meeting of the Advisory Committee on Immunization Practices (ACIP). Decision and cost-effectiveness analysis: maternal vaccination and cocooning. Atlanta, Georgia. June 22-23, 2011."}],"container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X12004521?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X12004521?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,2,8]],"date-time":"2022-02-08T13:05:13Z","timestamp":1644325513000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0213005X12004521"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":130,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S0213005X12004521"],"URL":"https:\/\/doi.org\/10.1016\/j.eimc.2012.12.011","relation":{},"ISSN":["0213-005X"],"issn-type":[{"value":"0213-005X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]}}}